LABCORP HOLDINGS INC. (LH) earnings date, results and what the price requires
NYSE · SEC CIK 0000920148 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $3.73B | $298.7M | $3.64 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $3.54B | $277.8M | $3.35 | Filing |
| Dec 31, 2025 | Feb 17, 2026 | $3.52B | $165.2M | $1.98 | Filing |
| Sep 30, 2025 | Oct 28, 2025 | $3.56B | $261.1M | $3.12 | Filing |
| Jun 30, 2025 | Jul 24, 2025 | $3.53B | $237.9M | $2.84 | Filing |
| Mar 31, 2025 | Apr 29, 2025 | $3.35B | $212.8M | $2.52 | Filing |
| Dec 31, 2024 | Feb 6, 2025 | $3.33B | $143.4M | $1.72 | Filing |
| Sep 30, 2024 | Oct 24, 2024 | $3.28B | $169.3M | $2.00 | Filing |
What would LABCORP HOLDINGS INC. have to report for its valuation to change?
At $325.07, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 18.1% a year, to $27.79. On that path the next quarter needs diluted EPS near $3.68, against $3.12 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 18.1% | 18.1% |
| EPS needed in final year | $27.79 | $27.79 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. LH goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.